Clinical Trials Directory

Trials / Completed

CompletedNCT00293241

PreFER Managed Ventricular Pacing (MVP) For Elective Replacement

PreFER MVP for Elective Replacement

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
630 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to demonstrate the benefit of MVP in pacemaker and implantable cardioverter defibrillator (ICD) patients with a history of right ventricular pacing.

Detailed description

A number of clinical studies (Danish I, Danish II, David, MOST) over the past few years have shown that, in patients with intact atrioventricular (AV) conduction, unnecessary chronic right ventricular (RV) pacing can cause a variety of detrimental effects, including atrial fibrillation (AF), left ventricular (LV) dysfunction, and congestive heart failure (CHF). These effects are believed to result from the mechanical dyssynchrony and ventricular chamber dysfunction that occurs with chronic, single-site, apical ventricular stimulation. Therefore a new pacing modality, Managed Ventricular Pacing (MVP), was designed to give preference to natural heart activity by minimizing unnecessary right ventricular pacing. This is accomplished by automatically switching between single chamber atrial and dual-chamber pacing based on specific patient needs. MVP is an atrial-based dual-chamber pacing mode that provides functional AAI/R pacing with ventricular monitoring and back-up DDD/R pacing only as needed during episodes of AV block. The reversibility of the detrimental effects caused by ventricular pacing has been initially investigated in small patient populations with short pacing durations in AAI and needs further investigation.

Conditions

Interventions

TypeNameDescription
DEVICEManaged Ventricular Pacing programmed ON/OFFDevice programming

Timeline

Start date
2006-02-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2006-02-17
Last updated
2016-06-24
Results posted
2015-06-30

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00293241. Inclusion in this directory is not an endorsement.